Medicare Price Negotiation: Sponsors Will Have A Say, But Likely Not Sway As Timetable Comes Into Focus

CMS details when it will release information and receive public comments in the lead-up to publishing the initial list of drugs to be negotiated this fall.

Opportunities For Manufacturers To Shape Program? • Source: Shutterstock

Although not required to by the Inflation Reduction Act, the Centers for Medicare and Medicaid Services will seek public comment on guidance and a handful of information collection requests covering the initial implementation of the Medicare price negotiation process over the next several months in an effort to leverage stakeholder expertise as it “thoughtfully” designs the program.

More from Market Access

More from Pink Sheet